Durata (DRTX) Files $86.25M IPO

March 22, 2012 4:09 PM EDT Send to a Friend
Get Alerts DRTX Hot Sheet
Trade DRTX Now!
Join SI Premium – FREE
Durata (Nasdaq: DRTX) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $86.25 million. Durata plans to list on the Nasdaq Global Market under the ticker, "DRTX."

The offering is being made through BofA Merrill Lynch, Credit Suisse, RBC Capital Markets, and Wedbush PacGrow Life Sciences.

Durata is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

IPOs

Related Entities

Credit Suisse, Merrill Lynch, Bank of America, RBC Capital

Add Your Comment